NO20093327L - Biomarkorer for multippel sklerose - Google Patents

Biomarkorer for multippel sklerose

Info

Publication number
NO20093327L
NO20093327L NO20093327A NO20093327A NO20093327L NO 20093327 L NO20093327 L NO 20093327L NO 20093327 A NO20093327 A NO 20093327A NO 20093327 A NO20093327 A NO 20093327A NO 20093327 L NO20093327 L NO 20093327L
Authority
NO
Norway
Prior art keywords
multiple sclerosis
biomarkers
diagnosis
identifying
individual
Prior art date
Application number
NO20093327A
Other languages
English (en)
Norwegian (no)
Inventor
Veerle Somers
Pieter Stinissen
Original Assignee
Apitope Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Int Nv filed Critical Apitope Int Nv
Publication of NO20093327L publication Critical patent/NO20093327L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20093327A 2007-04-12 2009-11-11 Biomarkorer for multippel sklerose NO20093327L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07106081 2007-04-12
PCT/EP2008/054479 WO2008125651A2 (fr) 2007-04-12 2008-04-14 Biomarqueurs pour la sclérose en plaques

Publications (1)

Publication Number Publication Date
NO20093327L true NO20093327L (no) 2009-12-02

Family

ID=39642898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20093327A NO20093327L (no) 2007-04-12 2009-11-11 Biomarkorer for multippel sklerose

Country Status (12)

Country Link
US (1) US8772225B2 (fr)
EP (2) EP2145182A2 (fr)
JP (1) JP2010523629A (fr)
CN (1) CN101680883A (fr)
AU (1) AU2008237878A1 (fr)
CA (1) CA2683865A1 (fr)
MX (1) MX2009011007A (fr)
NO (1) NO20093327L (fr)
PL (1) PL390236A1 (fr)
RU (1) RU2009141523A (fr)
WO (1) WO2008125651A2 (fr)
ZA (1) ZA200907027B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140273033A1 (en) * 2007-04-12 2014-09-18 Universiteit Hasselt Biomarkers for multiple sclerosis
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
EP2353004B1 (fr) 2008-11-12 2018-01-03 Yeda Research and Development Co. Ltd. Diagnostic de la sclérose en plaques
DK2569446T3 (en) * 2010-05-12 2018-10-29 Steven E Schutzer DIAGNOSTIC MARKERS FOR NEUROPsychiatric Disease
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
EP2596132A4 (fr) 2010-07-23 2013-12-18 Harvard College Procédés de détection de signatures de maladies ou pathologies dans des liquides biologiques
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2437060A1 (fr) * 2010-10-01 2012-04-04 Protagen AG Séquences de marqueurs pour la sclérose multiple et leur utilisation
WO2013135789A1 (fr) * 2012-03-15 2013-09-19 Universiteit Hasselt Moyens et procédés pour déterminer la vitesse de progression de la destruction articulaire chez des patients atteints de polyarthrite rhumatoïde (ra)
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (fr) 2013-03-09 2014-10-09 Harry Stylli Procédés de détection du cancer de la prostate
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US12448651B2 (en) 2018-12-12 2025-10-21 Hadasit Medical Research Services And Development Ltd. Markers of disease prognosis in multiple sclerosis
US11654988B2 (en) 2019-06-26 2023-05-23 Weel Autonomy Inc. Balancing system in an autonomous electronic bicycle
US10754340B1 (en) * 2019-06-26 2020-08-25 Weel Autonomy Inc. Virtual gearing in an autonomous electronic bicycle
CN117802214A (zh) * 2022-09-30 2024-04-02 厦门英博迈生物科技有限公司 多发性硬化诊断的标志物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20030092089A1 (en) 2001-11-14 2003-05-15 Moscarello Mario Anthony Method for diagnosing multiple sclerosis and an assay therefore
US20040043431A1 (en) 2002-08-29 2004-03-04 Aristo Vojdani Diagnosis of multiple sclerosis and other demyelinating diseases
WO2004034031A2 (fr) * 2002-10-11 2004-04-22 The Regents Of The University Of California Methode permettant de diagnostiquer et de pronostiquer la sclerose en plaques

Also Published As

Publication number Publication date
EP2579038A2 (fr) 2013-04-10
EP2579038A3 (fr) 2013-07-03
RU2009141523A (ru) 2011-05-20
US20100297678A1 (en) 2010-11-25
US8772225B2 (en) 2014-07-08
WO2008125651A2 (fr) 2008-10-23
EP2579038B1 (fr) 2014-10-01
WO2008125651A3 (fr) 2009-03-12
MX2009011007A (es) 2009-12-04
EP2145182A2 (fr) 2010-01-20
CN101680883A (zh) 2010-03-24
JP2010523629A (ja) 2010-07-15
ZA200907027B (en) 2010-12-29
AU2008237878A1 (en) 2008-10-23
PL390236A1 (pl) 2010-07-05
CA2683865A1 (fr) 2008-10-23

Similar Documents

Publication Publication Date Title
NO20093327L (no) Biomarkorer for multippel sklerose
CA2839777C (fr) Procedes de pronostic et/ou de diagnostic d'une maladie neurodegenerative, procedes d'identification de composes candidats et composes pour le traitement d'une maladie neurodegene rative
WO2010001419A3 (fr) Variations du nombre de copies prédictives d’un risque de schizophrénie
EA201291107A1 (ru) Соединения, ингибирующие металлоферменты
EA201490088A1 (ru) Соединения, ингибирующие металлоферменты
EA201490036A1 (ru) Соединения, ингибирующие металлоферменты
WO2010065929A3 (fr) Procédé de diagnostic de réactions allergiques
WO2013023144A3 (fr) Profils de biomarqueur de diagnostic pour détection et diagnostic de la maladie de parkinson
EA201101519A1 (ru) Способы диагностики метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
MX2013000502A (es) Metodos y kits para el diagnostico de cancer de prostata.
IN2014CN04326A (fr)
EP3981887A4 (fr) Biomarqueur pour le diagnostic de maladies du système nerveux cérébral
EA201390704A1 (ru) Соединения, ингибирующие металлоферменты
CA2796453C (fr) Systemes et procedes pour predire un trouble gastro-intestinal
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2011140208A3 (fr) Méthodes et compositions utilisables en vue du diagnostic et du traitement d'affections auto-immunes
WO2011044458A8 (fr) Compositions et méthodes de diagnostic de maladies et de troubles associés au génome
EA201300385A1 (ru) Улучшенный способ получения, главным образом, чистых гибридных семян злаков и машина для его применения
WO2012121978A3 (fr) Biomarqueurs pour diagnostic d'accident vasculaire cérébral lacunaire
WO2011143574A3 (fr) Marqueurs biologiques plasmatiques pour le diagnostic de la maladie d'alzheimer
WO2009149319A3 (fr) Profils d’expression de gène associés à des crises d’exacerbation d’asthme
WO2007047408A3 (fr) Application de signature promac
WO2011130647A3 (fr) Compositions et méthodes pour la caractérisation d'une myopathie
EP2490234A4 (fr) Cosse à languette pour condensateur électrolytique
WO2011092504A3 (fr) Marqueurs biologiques

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application